Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Prisco

Showing results (61-70 of 261) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|January 11, 2020
Treating the Different Phenotypes of Behçet's SyndromeAlessandra Bettiol, Gulen Hatemi, Lorenzo Vannozzi, et al.
European Journal of Internal Medicine|April 13, 2013
Improving the use of direct oral anticoagulants in atrial fibrillationGiovanni Di Minno, Anna Russolillo, Carminio Gambacorta, et al.
Internal and Emergency Medicine|October 27, 2018
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's diseaseGiuseppe Lopalco, Vincenzo Venerito, Luca Cantarini, et al.
Frontiers in Immunology|May 30, 2019
Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of NeutrophilsGiacomo Emmi, Matteo Becatti, Alessandra Bettiol, et al.
Seminars in Arthritis and Rheumatism|April 16, 2016
Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s diseaseGiacomo Emmi, Elena Silvestri, Danilo Squatrito, et al.
Clinical & Developmental Immunology|June 14, 2012
T cells in gastric cancer: friends or foesAmedeo Amedei, Chiara Della Bella, Elena Silvestri, et al.
Internal and Emergency Medicine|October 18, 2012
The risk stratification in atrial fibrillationDomenico Prisco, Caterina Cenci, Elena Silvestri, et al.
Journal of the American College of Cardiology|September 5, 2009
Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 yearsDaniela Poli, Emilia Antonucci, Elisa Grifoni, et al.
Thrombosis and Haemostasis|February 5, 2009
Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary preventionDaniela Poli, Emilia Antonucci, Elisa Grifoni, et al.
Haematologica|February 27, 2003
Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulationDaniela Poli, Emilia Antonucci, Alessandra Lombardi, et al.
Pageof 27

Showing results (61-70 of 261) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|January 11, 2020
Treating the Different Phenotypes of Behçet's SyndromeAlessandra Bettiol, Gulen Hatemi, Lorenzo Vannozzi, et al.
European Journal of Internal Medicine|April 13, 2013
Improving the use of direct oral anticoagulants in atrial fibrillationGiovanni Di Minno, Anna Russolillo, Carminio Gambacorta, et al.
Internal and Emergency Medicine|October 27, 2018
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's diseaseGiuseppe Lopalco, Vincenzo Venerito, Luca Cantarini, et al.
Frontiers in Immunology|May 30, 2019
Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of NeutrophilsGiacomo Emmi, Matteo Becatti, Alessandra Bettiol, et al.
Seminars in Arthritis and Rheumatism|April 16, 2016
Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s diseaseGiacomo Emmi, Elena Silvestri, Danilo Squatrito, et al.
Clinical & Developmental Immunology|June 14, 2012
T cells in gastric cancer: friends or foesAmedeo Amedei, Chiara Della Bella, Elena Silvestri, et al.
Internal and Emergency Medicine|October 18, 2012
The risk stratification in atrial fibrillationDomenico Prisco, Caterina Cenci, Elena Silvestri, et al.
Journal of the American College of Cardiology|September 5, 2009
Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 yearsDaniela Poli, Emilia Antonucci, Elisa Grifoni, et al.
Thrombosis and Haemostasis|February 5, 2009
Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary preventionDaniela Poli, Emilia Antonucci, Elisa Grifoni, et al.
Haematologica|February 27, 2003
Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulationDaniela Poli, Emilia Antonucci, Alessandra Lombardi, et al.
Pageof 27